LEGN News and Press, Legend Biotech Corporation From 06/03/24

2024-06-03 18:09:10 ET Read the full article on Seeking Alpha For further details see: J&J, Legend release promising results on Carvykti in earlier treatment line

First analysis of CARTITUDE-2 Cohort D study investigating CARVYKTI ® in multiple myeloma with suboptimal response after front-line ASCT featured in an oral presentation at the 2024 ASCO Annual Meeting show deep and durable responses with one-time infusion of CARVYKTI ® ...

2024-05-31 07:30:07 ET Citigroup analyst issues BUY recommendation for LEGN on May 31, 2024 05:30AM ET. The previous analyst recommendation was Buy. LEGN was trading at $43.33 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York, NY on Thursday, June 6,...

First disclosure from Cohort D of the Phase 2 CARTITUDE-2 study investigating CARVYKTI ® in patients who had suboptimal response to frontline ASCT in an oral presentation at ASCO & EHA An oral presentation at ASCO of data from the Phase 3 CARTITUDE-4 study evaluating CARVYKTI...

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 12.4% to $0.0886 on volume of 1,366,648,994 shares Ascent Solar Technologies Inc (ASTI) rose 63.4% to $0.2147 on volume of 656,794,712 shares Pineapple Energy Inc. (PEGY) rose 61.4% to $...

2024-05-23 11:59:46 ET More on Legend Biotech Legend Biotech's Carvykti Faces Stiff Challenges Despite Advances Legend Biotech Corporation 2024 Q1 - Results - Earnings Call Presentation Legend Biotech Corporation (LEGN) Q1 2024 Earnings Call Transcript Legend...

2024-05-23 10:15:06 ET Deutsche Bank analyst issues BUY recommendation for LEGN on May 23, 2024 08:36AM ET. LEGN was trading at $40.845 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 7 - Buy recommendati...

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 37.1% to $0.108 on volume of 436,246,446 shares Ascent Solar Technologies Inc (ASTI) rose 114.8% to $0.282249 on volume of 221,176,942 shares OneMedNet Corp (ONMD) rose 134.7% to $1.15 o...

2024-05-14 08:45:00 ET Summary Legend Biotech Corporation reported lower-than-expected Q1 earnings, reflecting struggles in Carvykti’s revenue generation despite strong market potential. Carvykti, despite superior indications compared to competitors, is hindered by high tox...